Chenguang Biotech Group (300138) — Cash Flow Reinvestment Rate
Chenguang Biotech Group (300138) has a Cash Flow Reinvestment Rate of 0.07x as of September 2025, reinvesting CN¥37.63 Million (capex CN¥37.63 Million ) from operating cash flow of CN¥524.96 Million. Explore Chenguang Biotech Group capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chenguang Biotech Group Cash Flow Reinvestment Rate (2008–2022)
Historical reinvestment intensity for Chenguang Biotech Group across 7 annual periods. Also explore total assets of Chenguang Biotech Group for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Chenguang Biotech Group (2008–2022)
Year-by-year capital reinvestment analysis for Chenguang Biotech Group. For live market cap and broader valuation context, see Chenguang Biotech Group market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.98x | CN¥716.94 Million | CN¥734.81 Million | CN¥176.03 Million | ▼ -92.4% |
| 2021 | 12.86x | CN¥821.73 Million | CN¥63.90 Million | CN¥280.82 Million | ▲ +1423.3% |
| 2020 | 0.84x | CN¥446.93 Million | CN¥529.41 Million | CN¥436.88 Million | ▲ +529.2% |
| 2014 | 0.13x | CN¥36.62 Million | CN¥272.96 Million | CN¥36.62 Million | ▼ -93.9% |
| 2011 | 2.21x | CN¥181.72 Million | CN¥82.18 Million | CN¥181.72 Million | ▼ -10.0% |
| 2009 | 2.46x | CN¥66.90 Million | CN¥27.23 Million | CN¥66.90 Million | ▼ -14.5% |
| 2008 | 2.87x | CN¥26.05 Million | CN¥9.06 Million | CN¥26.05 Million | — |